Walleye Capital
CDNA icon

Walleye Capital’s CareDx CDNA Stock Holding History

Walleye Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-258,430
Closed -$1.81M – 4986
2023
Q3 		$1.81M Sell
258,430
-68,809
-21% -$636K ﹤0.01% 1814
2023
Q2 		$2.78M Buy
327,239
+226,959
+226% +$1.89M 0.01% 1099
2023
Q1 		$917K Buy
100,280
+36,613
+58% +$468K 0.01% 1219
2022
Q4 		$726K Buy
+63,667
New +$943K 0.01% 1201
2022
Q3 		– Sell
-36,353
Closed -$781K – 3243
2022
Q2 		$781K Buy
+36,353
New +$1.01M 0.02% 774
2021
Q4 		– Sell
-5,537
Closed -$351 – 2126
2021
Q3 		$351 Buy
+5,537
New +$422K 0.01% 938
2021
Q2 		– Sell
-8,247
Closed -$562 – 1359
2021
Q1 		$562 Buy
+8,247
New +$640K 0.03% 551

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Walleye Capital's CDNA Position: Q4 2023 in Review

Walleye Capital sold out of CareDx (CDNA) in Q4 2023, closing a stake of 258,430 shares — an estimated $1.81M sold.

Walleye Capital first reported a position in CDNA in Q1 2021 and held it in 7 quarters. The position peaked at $2.78M in Q2 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q4 2023.

  • Walleye Capital reported no remaining CareDx position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 258,430 CareDx shares in Q4 2023, an estimated $1.81M.
  • Walleye Capital first reported a position in CareDx in Q1 2021 and held it in 7 quarters.
  • Walleye Capital's CareDx position peaked at $2.78M in Q2 2023.
  • 147 funds tracked by Wall St. Rank held CareDx as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.